ResMed: Remote monitoring, resupply improve compliance

Thursday, May 24, 2018

SAN DIEGO – Remote patient monitoring and resupply can improve patient adherence to PAP therapy, according to two studies presented by ResMed at the ATS 2018 International Conference. In the first study, medXcloud, a ResMed-assembled group of healthcare key opinion leaders, examined de-identified data of more than 2.6 million PAP users from its AirView network in the U.S. and found that 75% met the CMS compliance threshold. In the second study, ResMed and researchers found that over a one-year period patients who enrolled in a resupply program slept 5.6 hours on PAP each night, compared to 4.5 hours for those not enrolled. “These two studies demonstrate significantly effective ways to help patients achieve 90-day compliance with cloud-based remote monitoring and to keep them compliant over the long term with mask resupply programs,” said Adam Benjafield, researcher on both studies and ResMed’s vice president of medical affairs.